DCAF17
Basic information
Region (hg38): 2:171434217-171485052
Previous symbols: [ "C2orf37" ]
Links
Phenotypes
GenCC
Source:
- Woodhouse-Sakati syndrome (Limited), mode of inheritance: AR
- Woodhouse-Sakati syndrome (Strong), mode of inheritance: AR
- Woodhouse-Sakati syndrome (Strong), mode of inheritance: AR
- Woodhouse-Sakati syndrome (Strong), mode of inheritance: AR
- Woodhouse-Sakati syndrome (Supportive), mode of inheritance: AR
- Woodhouse-Sakati syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Woodhouse-Sakati syndrome | AR | Cardiovascular; Endocrine | Endocrine anomalies can include hypothyroidism and hypogonadism, and surveillance to allow appropriate medical care (eg, with replacement therapy, as well as care for manifestations such as diabetes mellitus) may be beneficial; Cardiac anomalies (including arrhythmia) have been reported, and surveillance and preventive measures may be beneficial; Awareness of hearing impairment may allow early interventions related to speech and language development | Audiologic/Otolaryngologic; Cardiovascular; Dermatologic; Endocrine; Neurologic | 6876115; 7710875; 19026396; 18049083; 18175354; 20507343; 21963443; 21964978 |
ClinVar
This is a list of variants' phenotypes submitted to
- Woodhouse-Sakati syndrome (25 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCAF17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 94 | 98 | ||||
missense | 85 | 12 | 97 | |||
nonsense | 7 | |||||
start loss | 3 | |||||
frameshift | 14 | 17 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 13 | |||||
splice region | 4 | 29 | 4 | 37 | ||
non coding | 59 | 112 | 47 | 219 | ||
Total | 25 | 13 | 145 | 218 | 54 |
Highest pathogenic variant AF is 0.0000132
Variants in DCAF17
This is a list of pathogenic ClinVar variants found in the DCAF17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-171434335-C-G | Woodhouse-Sakati syndrome | Uncertain significance (Jan 13, 2018) | ||
2-171434346-C-T | Woodhouse-Sakati syndrome | Uncertain significance (Apr 27, 2017) | ||
2-171434356-G-A | Woodhouse-Sakati syndrome | Uncertain significance (Jan 13, 2018) | ||
2-171434365-C-T | Woodhouse-Sakati syndrome | Conflicting classifications of pathogenicity (Feb 24, 2020) | ||
2-171434366-C-T | Woodhouse-Sakati syndrome | Uncertain significance (Jan 12, 2018) | ||
2-171434372-C-G | Woodhouse-Sakati syndrome | Uncertain significance (Jan 13, 2018) | ||
2-171434374-C-T | Woodhouse-Sakati syndrome | Uncertain significance (Jan 13, 2018) | ||
2-171434380-T-C | Woodhouse-Sakati syndrome | Uncertain significance (Jan 12, 2018) | ||
2-171434467-G-T | Woodhouse-Sakati syndrome | Uncertain significance (Jan 12, 2018) | ||
2-171434569-C-G | Woodhouse-Sakati syndrome | Uncertain significance (Jan 13, 2018) | ||
2-171434578-A-G | Woodhouse-Sakati syndrome | Pathogenic (Nov 17, 2023) | ||
2-171434578-A-T | Woodhouse-Sakati syndrome | Pathogenic (Feb 03, 2023) | ||
2-171434579-T-C | Woodhouse-Sakati syndrome | Pathogenic (Oct 23, 2023) | ||
2-171434586-G-T | Woodhouse-Sakati syndrome | Likely benign (Aug 25, 2023) | ||
2-171434593-A-C | Woodhouse-Sakati syndrome | Likely benign (Jan 29, 2024) | ||
2-171434595-G-C | Inborn genetic diseases • Woodhouse-Sakati syndrome | Uncertain significance (May 30, 2022) | ||
2-171434598-C-G | Woodhouse-Sakati syndrome | Likely benign (Oct 04, 2023) | ||
2-171434598-C-T | Woodhouse-Sakati syndrome | Likely benign (Oct 27, 2023) | ||
2-171434604-G-A | Woodhouse-Sakati syndrome | Conflicting classifications of pathogenicity (Jul 01, 2024) | ||
2-171434604-G-T | Woodhouse-Sakati syndrome | Likely benign (Apr 17, 2023) | ||
2-171434622-C-T | Woodhouse-Sakati syndrome | Likely benign (Jan 11, 2024) | ||
2-171434625-G-A | Woodhouse-Sakati syndrome | Likely benign (Mar 19, 2023) | ||
2-171434626-GC-G | Woodhouse-Sakati syndrome | Pathogenic (Dec 01, 2008) | ||
2-171434628-G-A | Woodhouse-Sakati syndrome | Likely benign (Jun 23, 2023) | ||
2-171434628-G-T | Woodhouse-Sakati syndrome • DCAF17-related disorder | Likely benign (Jan 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCAF17 | protein_coding | protein_coding | ENST00000375255 | 14 | 50836 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.74e-7 | 0.988 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.816 | 230 | 268 | 0.860 | 0.0000128 | 3387 |
Missense in Polyphen | 80 | 101.56 | 0.78774 | 1314 | ||
Synonymous | 0.562 | 84 | 90.8 | 0.925 | 0.00000420 | 974 |
Loss of Function | 2.30 | 15 | 28.2 | 0.533 | 0.00000128 | 364 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000232 | 0.000231 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000218 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. {ECO:0000269|PubMed:16949367}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Intolerance Scores
- loftool
- 0.840
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.25
Haploinsufficiency Scores
- pHI
- 0.0461
- hipred
- Y
- hipred_score
- 0.672
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dcaf17
- Phenotype
- reproductive system phenotype; cellular phenotype;
Gene ontology
- Biological process
- protein ubiquitination;post-translational protein modification
- Cellular component
- nucleoplasm;nucleolus;cytosol;integral component of membrane;Cul4-RING E3 ubiquitin ligase complex
- Molecular function
- protein binding